Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats

被引:16
|
作者
Xu, Xue [1 ]
Zhang, Lei [2 ]
Liang, Jiangjiu [1 ]
机构
[1] Shandong Univ, Dept Hlth Care, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Dept Orthoped, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
关键词
rosuvastatin; myocardial hypertrophy; pressure overload; Akt; extracellular signal-regulated kinase 1/2; GATA binding protein 4; INDUCED CARDIAC-HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; TRANSCRIPTION FACTOR GATA4; IN-VIVO; REGULATED KINASE; HEART-FAILURE; STRESS; ACTIVATION; REGRESSION; STATINS;
D O I
10.3892/mmr.2013.1548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pressure overload-induced myocardial hypertrophy is associated with a poor prognosis in humans and contributes to the development of cardiac arrhythmias, diastolic dysfunction and ultimate congestive heart failure. 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as statins, have been previously shown to induce regression of myocardial hypertrophy in aortic banding models. However, there is limited knowledge regarding the underlying molecular mechanisms. Therefore, we hypothesized that the myocardial hypertrophy-related signaling pathways protein kinase B (Akt), extracellular signal-regulated kinases 1 or 2 (ERK1/2) and GATA binding protein 4 (GATA4) activation pathways constitute targets of rosuvastatin (RSV). Therefore, the above-mentioned activation pathways were hypothesized to be involved in the regression of pressure overload-induced myocardial hypertrophy treated by RSV. Twenty-eight Wistar rats were randomly allocated into 4 groups: the sham operation-vehicle (SH-V), abdominal aortic constriction-vehicle (AAC-V), abdominal aortic constriction-RSV 10 mg/kg/day (AAC-LO) and the abdominal aortic constriction-RSV 20 mg/kg/day (AAC-HI) group. Following the establishment of the abdominal aorta constriction model, we investigated the effect of RSV, a new hydrophilic statin, on abdominal aortic constriction-induced myocardial hypertrophy as well as the underlying intercellular signaling pathways after 5 days and 4 weeks of drug intervention. Moreover, echocardiographic features and the left ventricular weight to final body weight ratio (LVW/BW) were determined. Cross-sectional areas (CSAs) of cardiomyocytes were assessed by hematoxylin and eosin (H&E) staining. Atrial natriuretic factor (ANF), beta-myosin heavy chain (beta-MHC) and peroxisome proliferator-activated receptor alpha (PPAR alpha) messenger RNA (mRNA) expression was assessed using RT-PCR. The phosphorylation of Akt, ERK1/2 and GATA4 were also examined using western blot analysis. Our results showed that RSV significantly attenuates pressure overload-induced myocardial hypertrophy by preventing myocardial hypertrophy-related activation of Akt, ERK1/2 and GATA4 signaling pathways.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 50 条
  • [21] Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling
    Chen, Yong
    He, Ting
    Zhang, Zhongjun
    Zhang, Junzhi
    PHARMACOLOGY, 2021, 106 (11-12) : 667 - 681
  • [22] Serinc2 antagonizes pressure overload-induced cardiac hypertrophy via regulating the amino acid/mTORC1 signaling pathway
    Mao, Shuai
    Yang, Manqi
    Liu, Huimin
    Wang, Shun
    Liu, Man
    Hu, Shan
    Liu, Beilei
    Ju, Hao
    Liu, Zheyu
    Huang, Min
    He, Shuijing
    Cheng, Mian
    Wu, Gang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (03):
  • [23] NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling
    Xu, Qi-rong
    Liu, Jin-long
    Zhu, Rong-rong
    Huang, Wen-xiong
    Huang, Huang
    Liu, Ji-chun
    Xu, Xin-ping
    Zhou, Xue-liang
    LIFE SCIENCES, 2023, 328
  • [24] Inhibition of Sema4D attenuates pressure overload-induced pathological myocardial hypertrophy via the MAPK/NF-κB/NLRP3 pathways
    Wu, Bing
    Xu, Cheng
    Xu, Changwu
    Qiu, Liqiang
    Gao, Ji-Xian
    Li, Ming
    Xiong, Yuanguo
    Xia, Hao
    Xia, Zhongyuan
    Liu, Xiaoxiong
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (03):
  • [25] Liraglutide-induced reduction of myocardial ischemia-reperfusion injury in rats via ERK1/2 signaling pathway
    Liu, Zhao-ying
    Ji, Qing-rong
    Hu, Shun-peng
    Zhou, Dong-hao
    Sun, Gui-ling
    Zhu, Pin-jun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (08) : 1835 - 1840
  • [26] HNF4α ubiquitination mediated by Peli1 impairs FAO and accelerates pressure overload-induced myocardial hypertrophy
    Hou, Yuxing
    Shi, Pengxi
    Du, Haiyang
    Zhu, Chenghao
    Tang, Chao
    Que, Linli
    Zhu, Guoqing
    Liu, Li
    Chen, Qi
    Li, Chuanfu
    Shao, Guoqiang
    Li, Yuehua
    Li, Jiantao
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [27] HNF4α ubiquitination mediated by Peli1 impairs FAO and accelerates pressure overload-induced myocardial hypertrophy
    Yuxing Hou
    Pengxi Shi
    Haiyang Du
    Chenghao Zhu
    Chao Tang
    Linli Que
    Guoqing Zhu
    Li Liu
    Qi Chen
    Chuanfu Li
    Guoqiang Shao
    Yuehua Li
    Jiantao Li
    Cell Death & Disease, 15
  • [28] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    QI Jianyong
    YU Juan
    HUANG Donghui
    GUO Liheng
    WANG Lei
    HUANG Xin
    HUANG Haiding
    ZHOU Miao
    ZHANG Minzhou
    Jiashin Wu
    Chinese Journal of Integrative Medicine, 2017, 23 (01) : 40 - 47
  • [29] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    Qi Jian-yong
    Yu Juan
    Huang Dong-hui
    Guo Li-heng
    Wang Lei
    Huang Xin
    Huang Hai-ding
    Zhou Miao
    Zhang Min-zhou
    Wu, Jiashin
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017, 23 (01) : 40 - 47
  • [30] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    QI Jian-yong
    YU Juan
    HUANG Dong-hui
    GUO Li-heng
    WANG Lei
    HUANG Xin
    HUANG Hai-ding
    ZHOU Miao
    ZHANG Min-zhou
    Jiashin Wu
    Chinese Journal of Integrative Medicine , 2017, (01) : 40 - 47